Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence S Kegeles

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
The American Journal of Psychiatry|May 3, 2016
Brain GABA Function and PsychosisLawrence S Kegeles
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|June 10, 2020
Gamma-Aminobutyric Acid, Glutamate, and Cognition in Early Stages of Psychosis: Are We Closing the Gap?Lawrence S Kegeles, Camilo de la Fuente-Sandoval
Annals of the New York Academy of Sciences|December 20, 2003
Glutamate, dopamine, and schizophrenia: from pathophysiology to treatmentMarc Laruelle, Lawrence S Kegeles, Anissa Abi-Dargham
NMR in Biomedicine|April 8, 2026
Q-MRS: Quantitative Magnetic Resonance Spectral Analysis Using Deep LearningChristopher J Wu, Lawrence S Kegeles, Douglas L Rothman, et al.
The Journal of Clinical Psychiatry|April 30, 2011
Rapid resolution of obsessions after an infusion of intravenous ketamine in a patient with treatment-resistant obsessive-compulsive disorderCarolyn I Rodriguez, Lawrence S Kegeles, Pamela Flood, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 26, 2003
Dopamine mediation of positive reinforcing effects of amphetamine in stimulant naïve healthy volunteers: results from a large cohortAnissa Abi-Dargham, Lawrence S Kegeles, Diana Martinez, et al.
Clinical Therapeutics|October 4, 2005
Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitationMarc Laruelle, W Gordon Frankle, Rajesh Narendran, et al.
Biological Psychiatry|January 27, 2009
Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjectsAnissa Abi-Dargham, Elsmarieke van de Giessen, Mark Slifstein, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 17, 2011
Maternal-fetal blood incompatibility and neuromorphologic anomalies in schizophrenia: Preliminary findingsDavid Freedman, Raymond Deicken, Lawrence S Kegeles, et al.
Nuclear Medicine and Biology|June 29, 2002
Pharmacokinetics and brain distribution in non human primate of R(-)[123I]DOI, A 5HT(2A/2C) serotonin agonistYolanda Zea-Ponce, Lawrence S Kegeles, Ningning Guo, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
The American Journal of Psychiatry|May 3, 2016
Brain GABA Function and PsychosisLawrence S Kegeles
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|June 10, 2020
Gamma-Aminobutyric Acid, Glutamate, and Cognition in Early Stages of Psychosis: Are We Closing the Gap?Lawrence S Kegeles, Camilo de la Fuente-Sandoval
Annals of the New York Academy of Sciences|December 20, 2003
Glutamate, dopamine, and schizophrenia: from pathophysiology to treatmentMarc Laruelle, Lawrence S Kegeles, Anissa Abi-Dargham
NMR in Biomedicine|April 8, 2026
Q-MRS: Quantitative Magnetic Resonance Spectral Analysis Using Deep LearningChristopher J Wu, Lawrence S Kegeles, Douglas L Rothman, et al.
The Journal of Clinical Psychiatry|April 30, 2011
Rapid resolution of obsessions after an infusion of intravenous ketamine in a patient with treatment-resistant obsessive-compulsive disorderCarolyn I Rodriguez, Lawrence S Kegeles, Pamela Flood, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 26, 2003
Dopamine mediation of positive reinforcing effects of amphetamine in stimulant naïve healthy volunteers: results from a large cohortAnissa Abi-Dargham, Lawrence S Kegeles, Diana Martinez, et al.
Clinical Therapeutics|October 4, 2005
Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitationMarc Laruelle, W Gordon Frankle, Rajesh Narendran, et al.
Biological Psychiatry|January 27, 2009
Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjectsAnissa Abi-Dargham, Elsmarieke van de Giessen, Mark Slifstein, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 17, 2011
Maternal-fetal blood incompatibility and neuromorphologic anomalies in schizophrenia: Preliminary findingsDavid Freedman, Raymond Deicken, Lawrence S Kegeles, et al.
Nuclear Medicine and Biology|June 29, 2002
Pharmacokinetics and brain distribution in non human primate of R(-)[123I]DOI, A 5HT(2A/2C) serotonin agonistYolanda Zea-Ponce, Lawrence S Kegeles, Ningning Guo, et al.
Pageof 8